The Journal of Musculoskeletal Medicine Vol 28 No 12

Pain Assessment Tool Update

December 02, 2011

An overview of available pain questionnaires provides both clinicians and researchers with a quick reference for comparing and selecting the most appropriate adult pain assessment tool for their purpose.

CNS Vasculitis: A Protean Manifestation of HIV/AIDS

November 30, 2011

A 42-year-old Hispanic woman with a past medical history of HIV infection and noncompliance with highly active antiretroviral therapy was admitted to the emergency department with a new-onset generalized tonic-clonic seizure episode, followed by Todd paralysis.

Identifying and Managing Scapular Problems in Overhead Athletes

November 30, 2011

The shoulder joint and scapula are inextricably linked-what affects the scapula will affect the shoulder, and vice versa. The scapula houses the glenoid, the bony socket that articulates with the humeral head; by virtue of the scapula's intimate association with shoulder joint motion, abnormalities of the scapula may cause and indicate intrinsic shoulder pathology.

New Axial and Peripheral Spondyloarthritis Classification Criteria

November 30, 2011

The spectrum of spondyloarthritis disorders-typically including ankylosing spondylitis, arthritis associated with inflammatory bowel disease, reactive arthritis, psoriatic arthritis, and undifferentiated SpA-are related clinically and genetically but are distinct entities.

Dupuytren Referrals and Awareness Lacking, Survey Shows

November 30, 2011

Close to half (41%) of patients with Dupuytren contracture are not receiving prompt referral to a specialist, visiting their general practitioner (GP)/doctor almost 3 times before being referred, according to a Pfizer UK Limited survey of 700 GPs from 6 European countries.

Key Osteoarthritis, Rheumatoid Arthritis, and Lupus Findings From ACR Meeting

November 12, 2011

Persons as young as 45 to 64 years will account for more than half of new diagnoses of knee osteoarthritis (OA) over the next decade as the rate of disease in younger persons increases. A vaccine designed to reeducate the immune system has been shown to be safe and feasible in the treatment of patients with rheumatoid arthritis (RA).